Market closedNon-fractional

Oric Pharmaceuticals/ORIC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Oric Pharmaceuticals

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.

Ticker

ORIC

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

South San Francisco, United States

Employees

102

ORIC Metrics

BasicAdvanced
$507M
Market cap
-
P/E ratio
-$1.78
EPS
1.18
Beta
-
Dividend rate
$507M
1.18
21.307
20.827
2.109
2.109
-24.70%
-38.30%
1.55
1.55
-4.466
-18.47%
-12.42%

What the Analysts think about ORIC

Analyst Ratings

Majority rating from 9 analysts.
Buy

ORIC Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$25M
-11.66%
Profit margin
0.00%
NaN%

ORIC Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 15.16%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.50
-$0.44
-$0.49
-$0.37
-
Expected
-$0.57
-$0.46
-$0.49
-$0.44
-$0.41
Surprise
-12.15%
-4.74%
0.73%
-15.16%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Oric Pharmaceuticals stock?

Oric Pharmaceuticals (ORIC) has a market cap of $507M as of July 05, 2024.

What is the P/E ratio for Oric Pharmaceuticals stock?

The price to earnings (P/E) ratio for Oric Pharmaceuticals (ORIC) stock is 0 as of July 05, 2024.

Does Oric Pharmaceuticals stock pay dividends?

No, Oric Pharmaceuticals (ORIC) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Oric Pharmaceuticals dividend payment date?

Oric Pharmaceuticals (ORIC) stock does not pay dividends to its shareholders.

What is the beta indicator for Oric Pharmaceuticals?

Oric Pharmaceuticals (ORIC) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Oric Pharmaceuticals stock

Buy or sell Oric Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing